← Back to Search

ED delirium & dementia screening & outpatient referral for Dementia (IMPACT Trial)

N/A
Waitlist Available
Led By Ula Hwang, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

IMPACT Trial Summary

This study is evaluating whether a process of screening, referral, and care coordination can improve outcomes for older ED patients who may have UCID.

Eligible Conditions
  • Dementia
  • Delirium
  • Cognitive Impairment
  • Emergency Care

IMPACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Diagnosed With Dementia Among Those With Completed Outpatient Assessment
Percentage of Patients With Confirmed Delirium or Dementia
Rates of Connection With Primary Care
+1 more

IMPACT Trial Design

1Treatment groups
Experimental Treatment
Group I: ED delirium & dementia screening & outpatient referralExperimental Treatment1 Intervention
Routine ED screening for delirium and memory problems with referral for outpatient assessment of cognitive impairment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
2021
N/A
~100

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,736,428 Total Patients Enrolled
7 Trials studying Dementia
2,584 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,964 Total Patients Enrolled
265 Trials studying Dementia
23,623,311 Patients Enrolled for Dementia
Ula Hwang, MDPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department
2021. "Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04846322.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top